Serotherapy vs. ex vivo T-cell depletion in unrelated donor marrow transplantation for pediatric hematologic malignancies.

被引：0
|
作者：
Przepiorka, D [1 ]
Khan, SP [1 ]
Rooney, C [1 ]
Kuehnle, I [1 ]
Heslop, H [1 ]
Gottschalk, S [1 ]
Bollard, C [1 ]
Brenner, MK [1 ]
Krance, R [1 ]
机构：
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2510
引用
收藏
页码：637A / 638A
页数：2
相关论文
共 50 条
  • [31] Comparison of partially mismatched related donor (PMRD) graft vs volunteer unrelated donor (VUD) transplant for high risk hematologic malignancies.
    Redei, I
    Langston, AA
    Jones, M
    Tanner, A
    Teagarden, D
    Lonial, S
    Cherry, J
    Bartlett, V
    Waller, EK
    BLOOD, 2001, 98 (11) : 386B - 386B
  • [32] To perform or not to perform T-cell depletion in unrelated stem cell transplantation?
    Zavrelova, A.
    Zak, P.
    Radocha, J.
    Cermanova, M.
    Lanska, M.
    Jebavy, L.
    Maly, J.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S113 - S113
  • [33] T-CELL DEPLETION IN BONE-MARROW TRANSPLANTATION
    BUTTURINI, A
    GALE, RP
    CLINICAL TRANSPLANTATION, 1989, 3 (03) : 122 - 128
  • [34] T-CELL DEPLETION IN BONE-MARROW TRANSPLANTATION
    POYNTON, CH
    BONE MARROW TRANSPLANTATION, 1988, 3 (04) : 265 - 279
  • [35] In vivo and ex vivo T-cell depleted (TCD) nonmyeloablativehaploidentical stem cell transplantation (NSCT) for hematologic malignancy (HM).
    Spitzer, TR
    McAfee, SL
    Bimalangshu, DR
    Ballen, K
    Attar, E
    Colby, C
    Preffer, F
    Saidman, S
    Shaffer, J
    Sachs, DH
    Sykes, M
    BLOOD, 2005, 106 (11) : 444B - 444B
  • [36] Similar survival after bone marrow versus peripheral blood stem cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel, R
    Laws, HJ
    Balzer, S
    Bernbeck, B
    Kramm, C
    Schoenberger, S
    Sinha, K
    Troeger, A
    Wernet, P
    Goebel, U
    Enczmann, J
    Dilloo, D
    BLOOD, 2005, 106 (11) : 584A - 584A
  • [37] Outcomes of Hematologic Malignancies after Unrelated Donor Hematopoietic Cell Transplantation According to Place of Residence
    Loberiza, Fausto R., Jr.
    Lee, Stephanie J.
    Klein, John P.
    Hassebroek, Anna
    Dehn, Jason G.
    Frangoul, Haydar A.
    Hahn, Theresa
    Hale, Gregory
    Lazarus, Hillard M.
    LeMaistre, Charles F.
    Maziarz, Richard T.
    Rizzo, J. Douglas
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (03) : 368 - 375
  • [38] Graft failure after "ex-vivo" T-cell depleted haploidentical transplantation in pediatric patients with high-risk hematological malignancies. A risk factors and outcomes analysis
    Diaz, Miguel A.
    Lopez, Ivan
    Molina, Blanca
    Pereto, Alba
    Zubicaray, Josune
    Sevilla, Julian
    Castillo, Ana
    Alenda, Raquel
    Moreno, Miguel A.
    Luis Vicario, Jose
    Gonzalez-Vicent, Marta
    LEUKEMIA & LYMPHOMA, 2021, 62 (13) : 3130 - 3137
  • [39] In vivo T cell depleted unrelated allogeneic stem cell transplantation with a reduced intensity regimen in patients with advanced hematologic malignancies
    Magalhaes-Silverman, M
    Carter, T
    Gingrich, R
    Hohl, R
    Schlueter, A
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 22 - 23
  • [40] Comparative Study of Haploidentical Transplant Followed by Post-transplant Cyclophosphamide and Selective Ex Vivo T-cell Depletion vs Unrelated Cord Blood Transplant for Adults with Haematological Malignancies
    Koh, Yin Jie
    Wu, Ian
    Linn, Yeh Ching
    Tan, Lip Kun
    Poon, Michelle
    Koh, Liang Piu
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 707 - 707
12345